Novel Research Could Help Reverse Damage Caused By COPD

A San Diego-based regenerative medicine company is pioneering a novel approach to treating Chronic Obstructive Pulmonary Disease (or COPD). A condition which affects over 400 million people worldwide and over 1.2 million across the UK.

Joining us on the Happy Hour to talk about the new treatment, is President, acting CEO and Co-Founder of SMSbiotech, Dr. Abdulkader Rahmo.

Image shows the RNIB Connect Radio logo. On a white background ‘RNIB’ written in bold black capital letters and underline with a bold pink line. Underneath the line: ‘Connect Radio’ is written in black in a smaller font.